Cargando…

Nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices

Objective: Active transcutaneous bone conduction devices consist of an external audio processor and an internal implant under intact skin. During the surgical procedure, it is important to verify the functionality of the implant before the surgical wound is closed. In a clinical study with the new b...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinfeldt, Sabine, Rigato, Cristina, Håkansson, Bo, Fredén Jansson, Karl-Johan, Eeg-Olofsson, Måns
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553998/
https://www.ncbi.nlm.nih.gov/pubmed/31239790
http://dx.doi.org/10.2147/MDER.S197919
_version_ 1783424905960751104
author Reinfeldt, Sabine
Rigato, Cristina
Håkansson, Bo
Fredén Jansson, Karl-Johan
Eeg-Olofsson, Måns
author_facet Reinfeldt, Sabine
Rigato, Cristina
Håkansson, Bo
Fredén Jansson, Karl-Johan
Eeg-Olofsson, Måns
author_sort Reinfeldt, Sabine
collection PubMed
description Objective: Active transcutaneous bone conduction devices consist of an external audio processor and an internal implant under intact skin. During the surgical procedure, it is important to verify the functionality of the implant before the surgical wound is closed. In a clinical study with the new bone conduction implant (BCI), the functionality of the implant was tested with an electric transmission test, where the output was the nasal sound pressure (NSP) recorded in the ipsilateral nostril. The same measurement was performed in all follow-up visits to monitor the implant's functionality and transmission to bone over time. The objective of this study was to investigate the validity of the NSP method as a tool to objectively verify the implant's performance intraoperatively, as well as to follow-up the implant's performance over time. Design: Thirteen patients with the BCI were included, and the NSP measurement was part of the clinical study protocol. The implant was electrically stimulated with an amplitude-modulated signal generator using a swept sine 0.1–10 kHz. The NSP was measured with a probe tube microphone in the ipsilateral nostril. Results: The NSP during surgery was above the noise floor for most patients within the frequency interval 0.4–5 kHz, showing NSP values for expected normal transmission of a functioning implant. Inter-subject comparison showed large variability, but follow-up results showed only minor variability within each subject. Further investigation showed that the NSP was stable over time. Conclusion: The NSP method is considered applicable to verify the implant's functionality during and after surgery. Such a method is important for implantable devices, but should be simplified and clinically adapted. Large variations between subjects were found, as well as smaller variability in intra-subject comparisons. As the NSP was found to not change significantly over time, stable transmission to bone, and implant functionality, were indicated.
format Online
Article
Text
id pubmed-6553998
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65539982019-06-25 Nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices Reinfeldt, Sabine Rigato, Cristina Håkansson, Bo Fredén Jansson, Karl-Johan Eeg-Olofsson, Måns Med Devices (Auckl) Original Research Objective: Active transcutaneous bone conduction devices consist of an external audio processor and an internal implant under intact skin. During the surgical procedure, it is important to verify the functionality of the implant before the surgical wound is closed. In a clinical study with the new bone conduction implant (BCI), the functionality of the implant was tested with an electric transmission test, where the output was the nasal sound pressure (NSP) recorded in the ipsilateral nostril. The same measurement was performed in all follow-up visits to monitor the implant's functionality and transmission to bone over time. The objective of this study was to investigate the validity of the NSP method as a tool to objectively verify the implant's performance intraoperatively, as well as to follow-up the implant's performance over time. Design: Thirteen patients with the BCI were included, and the NSP measurement was part of the clinical study protocol. The implant was electrically stimulated with an amplitude-modulated signal generator using a swept sine 0.1–10 kHz. The NSP was measured with a probe tube microphone in the ipsilateral nostril. Results: The NSP during surgery was above the noise floor for most patients within the frequency interval 0.4–5 kHz, showing NSP values for expected normal transmission of a functioning implant. Inter-subject comparison showed large variability, but follow-up results showed only minor variability within each subject. Further investigation showed that the NSP was stable over time. Conclusion: The NSP method is considered applicable to verify the implant's functionality during and after surgery. Such a method is important for implantable devices, but should be simplified and clinically adapted. Large variations between subjects were found, as well as smaller variability in intra-subject comparisons. As the NSP was found to not change significantly over time, stable transmission to bone, and implant functionality, were indicated. Dove 2019-05-28 /pmc/articles/PMC6553998/ /pubmed/31239790 http://dx.doi.org/10.2147/MDER.S197919 Text en © 2019 Reinfeldt et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Reinfeldt, Sabine
Rigato, Cristina
Håkansson, Bo
Fredén Jansson, Karl-Johan
Eeg-Olofsson, Måns
Nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices
title Nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices
title_full Nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices
title_fullStr Nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices
title_full_unstemmed Nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices
title_short Nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices
title_sort nasal sound pressure as objective verification of implant in active transcutaneous bone conduction devices
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553998/
https://www.ncbi.nlm.nih.gov/pubmed/31239790
http://dx.doi.org/10.2147/MDER.S197919
work_keys_str_mv AT reinfeldtsabine nasalsoundpressureasobjectiveverificationofimplantinactivetranscutaneousboneconductiondevices
AT rigatocristina nasalsoundpressureasobjectiveverificationofimplantinactivetranscutaneousboneconductiondevices
AT hakanssonbo nasalsoundpressureasobjectiveverificationofimplantinactivetranscutaneousboneconductiondevices
AT fredenjanssonkarljohan nasalsoundpressureasobjectiveverificationofimplantinactivetranscutaneousboneconductiondevices
AT eegolofssonmans nasalsoundpressureasobjectiveverificationofimplantinactivetranscutaneousboneconductiondevices